Market Overview

UPDATE: Jefferies Raises PT to $10 on Amedisys, Maintains Neutral on Reimbursement Uncertainty

Related AMED
Benzinga's Top Upgrades
Stocks To Watch For June 30, 2014

Jefferies maintained Amedisys (NASDAQ: AMED) with a Hold and raised the price target from $9.00 to $10.00.

Jefferies analyst Brian Tanquilut wrote, "We continue to have a cautious view on AMED given our belief that ongoing budget discussions in DC could yield incremental rate cuts for home nursing providers such as AMED. Additionally, we are concerned that ongoing volume pressure (from persistent weakness in recertifications) will impact AMED's ability to offset upcoming rate cuts and drive LT EPS growth."

Amedisys closed at $11.19 on Wednesday.

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (AMED)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free